Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care.
REPROHEP
1 other identifier
observational
124
0 countries
N/A
Brief Summary
The main objective of this work is to assess the intraoperator reproducibility in the calculation of the HEP score in a population of intensive care patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2021
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 2, 2021
CompletedFirst Posted
Study publicly available on registry
March 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedMarch 4, 2021
February 1, 2021
2 months
March 2, 2021
March 2, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraobserver agreeement for the HEP score
Intraobserver agreeement for the HEP score
3 months
Secondary Outcomes (1)
Interobserver agreement for the HEP score
3 months
Study Arms (1)
Cohort
he retrospective cohort studied includes all the patients included in a previous study carried out in our center, the objective of which was to study the diagnostic performance of the HEP score in surgical intensive care. The cohort studied is made up of all patients admitted for surgical resuscitation between October 2011 and October 2013 and validating the following criteria: * Inclusion criteria: any adult patient (age ≥ 18 years), admitted to surgical intensive care, treated with heparin (UFH or LMWH), and suspected of TIH by a clinician in the department according to the criteria of the SFAR 2002. * Non-inclusion criteria: minor patients, pregnant women and adults incapable.
Interventions
Eligibility Criteria
The cohort studied is made up of all patients admitted for surgical resuscitation between October 2011 and October 2013
You may qualify if:
- any adult patient (age ≥ 18 years), admitted to surgical intensive care, treated with heparin (UFH or LMWH), and suspected of TIH by a clinician in the department according to the criteria of the SFAR 2002.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K, Propert KJ, Kuter DJ, Ortel TL, Konkle BA, Cines DB. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost. 2010 Dec;8(12):2642-50. doi: 10.1111/j.1538-7836.2010.04059.x.
PMID: 20854372RESULT
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Guillaume Besch, MD
CHRU J. Minjoz à Besançon
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2021
First Posted
March 4, 2021
Study Start
March 1, 2021
Primary Completion
May 1, 2021
Study Completion
May 1, 2021
Last Updated
March 4, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share